HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Intralesional agents show promise in melanoma but may serve ‘narrow clientele’
-
- Music therapy significantly reduces preoperative anxiety among women undergoing breast surgery
- Ohio State University Wexner Medical Center appoints urology chair
- Rutgers Cancer Institute names program director
- Wistar Institute executive receives professorship
- ASCO: A mixed bag of positives, negatives, promises for the future John Sweetenham, MD, FRCP, FACP
- HPV-16 genotype associated with longer OS in HNSCC
- 10-year survival outcomes decrease for multiple melanoma patients
- Necrotizing enterocolitis linked to severe anemia, not transfusion, in very low-birth-weight infants
-
- Off-label therapies show benefit for patients with advanced, mutated cancers
- One-third of female physician–scientists report sexual harassment
- Patients shop around most for colonoscopies, mammograms
- Somatic mosaic mutations in ovarian cancer linked to chemotherapy exposure, age
- Survey: Physicians expect to prescribe more biosimilars in the next 3 years
- Adjuvant temozolomide prolongs OS, PFS in certain patients with anaplastic glioma
- Age, complications influence death after colon cancer surgery
- Avelumab induces durable responses in advanced Merkel cell carcinoma
-
- Chimeric antigen receptor T cells produce robust responses in relapsed, refractory CLL
- Daratumumab combination improves PFS, ORR in relapsed, refractory multiple myeloma
- Higher, split doses may reduce toxicity of CTL019 in adult ALL
- Isatuximab active in relapsed, refractory multiple myeloma
- Longer anticoagulation therapy may reduce VTE recurrence in patients with cancer
- Molecular alterations of extrapulmonary neuroendocrine carcinomas differ by tumor site
- Nivolumab demonstrates encouraging activity in metastatic colorectal cancer
- Novel anti-GD2 antibody demonstrates activity in pediatric neuroblastoma
-
- Physician–parent communication necessary to understand risk for late effects from pediatric cancer
- Surgeon preference influences likelihood of mastectomy
- Tandem therapy improves outcomes for children with neuroblastoma
- Trastuzumab biosimilar safe, effective for advanced breast cancer
- Web application-guided follow-up may improve survival in high-risk lung cancer